FBR Capital initiates coverage on Biogen (NASDAQ: BIIB) with a Market Perform. PT $259.00.

Analyst William Tanner, Ph.D comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

New Coverage

Biogen (BIIB) PT Raised to $300 at Jefferies Post Q3October 29, 2013 12:16 PM